(MedPage Today) — For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization has clinical benefits.
At…
Source link : https://www.medpagetoday.com/meetingcoverage/europcr/115681
Author :
Publish date : 2025-05-20 20:26:00
Copyright for syndicated content belongs to the linked Source.
